ecrin-mdr-crcClinical2022Colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/38819China4ECRIN MDRNot yet recruitingfalseA prospective, single-arm, single-center clinical study of Sintilizumab+bevacizumab combined with standard chemotherapy in the second-line treatment of metastatic colorectal cancerInterventions: test group:Sintilizumab combined with bevacizumab Primary outcome(s): Disease-free survival Study Design: Single arm2022-04-1538819ChiCTR2200058633